Keros Therapeutics Inc

Biotech Stocks Healthcare Stocks

$11.19

-0.17 (-1.50%)

As of Sep 20, 10:25 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 4 31%

Sell 0 0%

Price Target

Analyst Price Target +76.1% upside

Low Target $13.49

Average Target $19.70

High Target $20.36

Current Price $11.19

Current
$11.19

Target
$19.70

$13.49 $19.70 avg $20.36

Scenario Analysis

Bear Case

$13.49

20.6%

Low target

Base Case

$19.70

+76.1%

Avg target

Bull Case

$20.36

+81.9%

High target

Risk/Reward

4.0x

Highly favorable

Price in Context

52-Week High

$22.55

-50.4% from high

52-Week Low

$9.69

+15.5% from low

Target vs 52W High

$19.70

-12.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%